Escitalopram: Your brand is changing

Brand change Active

Pharmac is changing the funded brand of escitalopram tablets. These tablets are currently available in different strengths – 10 mg and 20 mg.

 Escitalopram is used to help manage a range of mental health conditions, such as depression and anxiety. 

What’s changing?

The funded brand of escitalopram is changing to the Ethics-Escitalopram brand from the Apo-Escitalopram brand.

This brand change was unavoidable because Apotex, the supplier of Apo-Escitalopram, is leaving the New Zealand market.  

Your new brand is currently available

Since 1 May 2021 the Ethics-Escitalopram brand of escitalopram has been fully funded and available for patients. Apo-Escitalopram is still available.

From 1 October 2021 only the Ethics-Escitalopram brand of escitalopram will be fully funded. Apo-Escitalopram will no longer be available. 

Ethics-Escitalopram works the same as other brands

  • Ethics-Escitalopram works the same as the Apotex brand of escitalopram.
  • Ethics-Escitalopram has the same active ingredient as other brands of escitalopram and is delivered in the body in the same way. This means it will have the same effect as other brands.
  • Ethics-Escitalopram has been evaluated by Medsafe to ensure it’s safe and works the same as other brands.
  • Ethics-Escitalopram will still come in a 28-tablet blister pack.

Your Ethics-Escitalopram will look a bit different to the brand you’re used to. Ethics-Escitalopram is a white round tablet.

Both Apo-Escitalopram and Ethics-Escitalopram are generic brands. 

Read more about generic medicines

Find out more

If you have any questions or concerns about changing brands, talk with your doctor, nurse or pharmacist. You can also get more information from us at enquiry@pharmac.govt.nz or 0800 66 00 50.